Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Intravenous Iron Market

ID: MRFR/Pharma/66561-CR
130 Pages
Rahul Gotadki
Last Updated: April 22, 2026

Intravenous Iron Market Research Report: Information by Product Type (Ferric Carboxymaltose, Ferumoxytol, Iron Sucrose, Iron Isomaltoside, Ferric Gluconate, Iron Dextran, Others), By Application (Anemia in Chronic Kidney Disease (CKD), Anemia in Oncology, Iron Deficiency in Heart Failure, Iron Deficiency Anemia (IDA) in Non-Dialysis Patients, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By End User(Hospitals and Clinics, Specialized Infusion Centers, Others)By Region (North America, Europe, Asia-Pacific, Rest of the World) -Global Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Intravenous Iron Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 EXECUTIVE SUMMARY
  2. 2 MARKET INTRODUCTION
    1. 2.1 DEFINITION
    2. 2.2 SCOPE OF THE STUDY
    3. 2.3 RESEARCH OBJECTIVE
    4. 2.4 MARKET STRUCTURE
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 OVERVIEW
    2. 3.2 DATA FLOW
      1. 3.2.1 Data Mining Process
    3. 3.3 PURCHASED DATABASE:
    4. 3.4 SECONDARY SOURCES:
      1. 3.4.1 Secondary Research data flow:
    5. 3.5 PRIMARY RESEARCH:
      1. 3.5.1 Primary Research DATA FLOW:
      2. 3.5.2 Primary Research: Number of Interviews conducted
      3. 3.5.3 Primary Research: Regional Coverage
    6. 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
      1. 3.6.1 Revenue Analysis Approach
    7. 3.7 DATA FORECASTING
      1. 3.7.1 Data forecasting Technique
    8. 3.8 DATA MODELING
      1. 3.8.1 microeconomic factor analysis:
      2. 3.8.2 Data modeling:
    9. 3.9 TEAMS AND ANALYST CONTRIBUTION
  4. 4 MARKET DYNAMICS
    1. 4.1 INTRODUCTION
    2. 4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS
    3. 4.3 DRIVERS
      1. 4.3.1 Clinical Superiority in Inflammation-Driven Iron Deficiency Rising need for continuous surveillance of submerged ocean areas
      2. 4.3.2 Hospital Efficiency and Resource Optimization
      3. 4.3.3 Guideline-Driven, Protocolized Demand
    4. 4.4 RESTRAINTS
      1. 4.4.1 High Treatment and Administration Costs
      2. 4.4.2 SAFETY Monitoring and Infrastructure Requirements
      3. 4.4.3 Underdiagnosis and Inconsistent Screening Practices
    5. 4.5 OPPORTUNITY
      1. 4.5.1 Expansion of IV Iron Use in Outpatient and Day-Care Settings
      2. 4.5.2 Rising Focus on Blood Management and Transfusion Reduction
      3. 4.5.3 Untapped Demand in Emerging and Underserved Markets
  5. 5 MARKET FACTOR ANALYSIS
    1. 5.1 REGULATORY ENVIRONMENT & COMPLIANCE
    2. 5.2 MARKET TRENDS & INNOVATION
    3. 5.3 PATIENT DEMOGRAPHICS & DISEASE BURDENS
      1. 5.3.1 Anemia in Chronic Kidney Disease (CKD)
      2. 5.3.2 Anemia in oncology
      3. 5.3.3 iron deficiency in heart failure
      4. 5.3.4 Iron Deficiency Anemia (IDA) in Non-Dialysis Patients
    4. 5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS
      1. 5.4.1 Pricing Analysis
        1. 5.4.1.1 North America
          1. 5.4.1.1.1 North America Pricing Analysis, By Product
        2. 5.4.1.2 Europe
          1. 5.4.1.2.1 Europe Pricing Analysis, By Product
        3. 5.4.1.3 APAC
          1. 5.4.1.3.1 APAC Pricing Analysis, By Product
        4. 5.4.1.4 Rest of the World
          1. 5.4.1.4.1 Rest of the World Pricing Analysis, By Product
      2. 5.4.2 reimbursement dynamics
    5. 5.5 MARKET ENTRY & EXIT BARRIERS
      1. 5.5.1 Barriers to Entry
      2. 5.5.2 Barriers to exit
    6. 5.6 PARTNERSHIPS & COLLABORATIONS
    7. 5.7 PESTLE ANALYSIS
      1. 5.7.1 Political Factors
      2. 5.7.2 Economic Factors
      3. 5.7.3 Social Factors
      4. 5.7.4 Technological Factors
      5. 5.7.5 Legal Factors
      6. 5.7.6 Environmental Factors
    8. 5.8 PORTER’S FIVE FORCES MODEL
      1. 5.8.1 Bargaining Power of Suppliers
      2. 5.8.2 Bargaining Power of Buyers
      3. 5.8.3 Threat of New Entrants
      4. 5.8.4 Threat of Substitutes
      5. 5.8.5 Intensity of Rivalry
    9. 5.9 CASE STUDY ANALYSIS
    10. 5.10 INVESTMENT & FUNDING SCENARIOS
    11. 5.11 POST-MARKET SURVEILLANCE & SAFETY DATA
    12. 5.12 PRODUCT PIPELINE ANALYSIS
      1. 5.12.1 product pipeline analysis
  6. 6 GLOBAL INTRAVENOUS (IV) IRON MARKET-BY PRODUCT TYPE
    1. 6.1 INTRODUCTION
    2. 6.2 FERRIC CARBOXYMALTOSE
    3. 6.3 FERUMOXYTOL
    4. 6.4 IRON SUCROSE
    5. 6.5 IRON ISOMALTOSIDE
    6. 6.6 FERRIC GLUCONATE
    7. 6.7 IRON DEXTRAN
    8. 6.8 OTHERS
  7. 7 GLOBAL INTRAVENOUS (IV) IRON MARKET-BY APPLICATION
    1. 7.1 INTRODUCTION
    2. 7.2 Anemia in Chronic Kidney Disease (CKD)
    3. 7.3 ANEMIA IN ONCOLOGY
    4. 7.4 IRON DEFICIENCY IN HEART FAILURE
    5. 7.5 IRON DEFICIENCY ANEMIA (IDA) IN NON-DIALYSIS PATIENTS
    6. 7.6 OTHERS
  8. 8 GLOBAL INTRAVENOUS (IV) IRON MARKET-BY DISTRIBUTION CHANNEL
    1. 8.1 INTRODUCTION
    2. 8.2 RETAIL PHARMACY
    3. 8.3 HOSPITAL PHARMACY
    4. 8.4 ONLINE PHARMACY
  9. 9 GLOBAL INTRAVENOUS (IV) IRON MARKET-BY END USER
    1. 9.1 INTRODUCTION
    2. 9.2 HOSPITAL AND CLINICS
    3. 9.3 SPECIALISED INFUSION CENTERS
    4. 9.4 OTHERS
  10. 10 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY REGION
    1. 10.1 OVERVIEW
      1. 10.1.1 Global Intravenous (IV) Iron Marke, by Region, 2023 VS 2032 (USD MILLION)
      2. 10.1.2 Global Intravenous (IV) Iron MarkeT, BY Region, 2019–2035 (USD mILLION)
    2. 10.2 NORTH AMERICA
      1. 10.2.1 US
      2. 10.2.2 canada
    3. 10.3 EUROPE
      1. 10.3.1 GERMANY
      2. 10.3.2 FRANCE
      3. 10.3.3 UK
      4. 10.3.4 SPAIN
      5. 10.3.5 ITALY
      6. 10.3.6 Rest of Europe
    4. 10.4 ASIA-PACIFIC
      1. 10.4.1 CHINA
      2. 10.4.2 india
      3. 10.4.3 japan
      4. 10.4.4 South Korea
      5. 10.4.5 australia
      6. 10.4.6 NEW ZEALAND
      7. 10.4.7 INDONESIA
      8. 10.4.8 Rest of Asia-Pacific
    5. 10.5 SOUTH AMERICA
      1. 10.5.1 brazil
      2. 10.5.2 mexico
      3. 10.5.3 argentina
      4. 10.5.4 Rest of South America
    6. 10.6 MIDDLE EAST AND AFRICA
      1. 10.6.1 gcc cOUNTries
      2. 10.6.2 south africa
      3. 10.6.3 Rest of Middle East & Africa
  11. 11 COMPETITIVE LANDSCAPE
    1. 11.1 INTRODUCTION
    2. 11.2 COMPANY MARKET SHARE ANALYSIS, 2024
    3. 11.3 COMPETITOR DASHBOARD
    4. 11.4 PUBLIC PLAYERS STOCK SUMMARY
    5. 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
    6. 11.6 COMPETITOR'S PRODUCT INFORMATION/ PRODUCT BENCHMARKING ANALYSIS
    7. 11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
      1. 11.7.1 NEW PRODUCT LAUNCH/ DEVELOPMENT
      2. 11.7.2 PARTNERSHIP/COLLABORATION, INVESTMENT, EXPANSION, AND OTHERS
  12. 12 COMPANY PROFILES
    1. 12.1 ABBVIE INC.
      1. 12.1.1 COMPANY OVERVIEW
      2. 12.1.2 FINANCIAL OVERVIEW
      3. 12.1.3 PRODUCTS OFFERed
      4. 12.1.4 KEY DEVELOPMENTS
      5. 12.1.5 SWOT ANALYSIS
      6. 12.1.6 Key Strategies
    2. 12.2 AZURITY PHARMACEUTICALS
      1. 12.2.1 COMPANY OVERVIEW
      2. 12.2.2 FINANCIAL OVERVIEW
      3. 12.2.3 PRODUCTS OFFERed
      4. 12.2.4 KEY DEVELOPMENTS
      5. 12.2.5 SWOT ANALYSIS
      6. 12.2.6 Key Strategies
    3. 12.3 DAIICHI SANKYO COMPANY, LTD.
      1. 12.3.1 COMPANY OVERVIEW
      2. 12.3.2 FINANCIAL OVERVIEW
      3. 12.3.3 PRODUCTS OFFERed
      4. 12.3.4 KEY DEVELOPMENTS
      5. 12.3.5 SWOT ANALYSIS
      6. 12.3.6 Key Strategies
    4. 12.4 SANOFI
      1. 12.4.1 COMPANY OVERVIEW
      2. 12.4.2 FINANCIAL OVERVIEW
      3. 12.4.3 PRODUCTS OFFERed
      4. 12.4.4 KEY DEVELOPMENTS
      5. 12.4.5 SWOT ANALYSIS
      6. 12.4.6 Key Strategies
    5. 12.5 VIFOR PHARMA (CSL)
      1. 12.5.1 COMPANY OVERVIEW
      2. 12.5.2 FINANCIAL OVERVIEW
      3. 12.5.3 PRODUCTS OFFERed
      4. 12.5.4 KEY DEVELOPMENTS
      5. 12.5.5 SWOT ANALYSIS
      6. 12.5.6 Key Strategies
    6. 12.6 PHARMACOSMOS A/S.
      1. 12.6.1 COMPANY OVERVIEW
      2. 12.6.2 FINANCIAL OVERVIEW
      3. 12.6.3 PRODUCTS OFFERed
      4. 12.6.4 KEY DEVELOPMENTS
      5. 12.6.5 SWOT ANALYSIS
      6. 12.6.6 Key Strategies
    7. 12.7 ZYDUS GROUP
      1. 12.7.1 COMPANY OVERVIEW
      2. 12.7.2 FINANCIAL OVERVIEW
      3. 12.7.3 PRODUCTS OFFERed
      4. 12.7.4 KEY DEVELOPMENTS
      5. 12.7.5 SWOT ANALYSIS
      6. 12.7.6 Key Strategies
    8. 12.8 ROCKWELL MEDICAL, INC.
      1. 12.8.1 COMPANY OVERVIEW
      2. 12.8.2 FINANCIAL OVERVIEW
      3. 12.8.3 PRODUCTS OFFERed
      4. 12.8.4 KEY DEVELOPMENTS
      5. 12.8.5 SWOT ANALYSIS
      6. 12.8.6 Key Strategies
    9. 12.9 SHIELD THERAPEUTICS
      1. 12.9.1 COMPANY OVERVIEW
      2. 12.9.2 FINANCIAL OVERVIEW
      3. 12.9.3 PRODUCTS OFFERed
      4. 12.9.4 KEY DEVELOPMENTS
      5. 12.9.5 SWOT ANALYSIS
      6. 12.9.6 Key Strategies
    10. 12.10 AMERICAN REGENT, INC
      1. 12.10.1 COMPANY OVERVIEW
      2. 12.10.2 FINANCIAL OVERVIEW
      3. 12.10.3 PRODUCTS OFFERed
      4. 12.10.4 KEY DEVELOPMENTS
      5. 12.10.5 SWOT ANALYSIS
      6. 12.10.6 Key Strategies
    11. 12.11 DATA CITATIONS
  13. LIST OF TABLES
  14. TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  15. TABLE 2 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  16. TABLE 3 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  17. TABLE 4 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  18. TABLE 5 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  19. TABLE 6 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY REGION, 2019–2032 (USD MILLION)
  20. TABLE 7 NORTH AMERICA: INTRAVENOUS (IV) IRON MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  21. TABLE 8 NORTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  22. TABLE 9 NORTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  23. TABLE 10 NORTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  24. TABLE 11 NORTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  25. TABLE 12 US INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  26. TABLE 13 US INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  27. TABLE 14 US INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  28. TABLE 15 US INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  29. TABLE 16 CANADA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  30. TABLE 17 CANADA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  31. TABLE 18 CANADA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  32. TABLE 19 CANADA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  33. TABLE 20 EUROPE: INTRAVENOUS (IV) IRON (UUV) MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  34. TABLE 21 EUROPE INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  35. TABLE 22 EUROPE INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  36. TABLE 23 EUROPE INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  37. TABLE 24 EUROPE INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  38. TABLE 25 GERMANY INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  39. TABLE 26 GERMANY INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  40. TABLE 27 GERMANY INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  41. TABLE 28 GERMANY INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  42. TABLE 29 FRANCE INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  43. TABLE 30 FRANCE INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  44. TABLE 31 FRANCE INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  45. TABLE 32 FRANCE INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  46. TABLE 33 UK INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  47. TABLE 34 UK INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  48. TABLE 35 UK INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  49. TABLE 36 UK INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  50. TABLE 37 SPAIN INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  51. TABLE 38 SPAIN INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  52. TABLE 39 SPAIN INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  53. TABLE 40 SPAIN INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  54. TABLE 41 ITALY INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  55. TABLE 42 ITALY INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  56. TABLE 43 ITALY INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  57. TABLE 44 ITALY INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  58. TABLE 45 REST OF EUROPE INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  59. TABLE 46 REST OF EUROPE INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  60. TABLE 47 REST OF EUROPE INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  61. TABLE 48 REST OF EUROPE INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  62. TABLE 49 ASIA-PACIFIC: INTRAVENOUS (IV) IRON MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  63. TABLE 50 ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  64. TABLE 51 ASIA-PACIFC INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  65. TABLE 52 ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  66. TABLE 53 ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  67. TABLE 54 CHINA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  68. TABLE 55 CHINA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  69. TABLE 56 CHINA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  70. TABLE 57 CHINA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  71. TABLE 58 INDIA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  72. TABLE 59 INDIA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  73. TABLE 60 INDIA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  74. TABLE 61 INDIA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  75. TABLE 62 JAPAN INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  76. TABLE 63 JAPAN INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  77. TABLE 64 JAPAN INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  78. TABLE 65 JAPAN INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  79. TABLE 66 SOUTH KOREA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  80. TABLE 67 SOUTH KOREA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  81. TABLE 68 SOUTH KOREA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  82. TABLE 69 SOUTH KOREA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  83. TABLE 70 AUSTRALIA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  84. TABLE 71 AUSTRALIA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  85. TABLE 72 AUSTRALIA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  86. TABLE 73 AUSTRALIA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  87. TABLE 74 NEW ZEALAND INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  88. TABLE 75 NEW ZEALAND INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  89. TABLE 76 NEW ZEALAND INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  90. TABLE 77 NEW ZEALAND INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  91. TABLE 78 INDONESIA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  92. TABLE 79 INDONESIA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  93. TABLE 80 INDONESIA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  94. TABLE 81 INDONESIA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  95. TABLE 82 REST OF ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  96. TABLE 83 REST OF ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  97. TABLE 84 REST OF ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  98. TABLE 85 REST OF ASIA-PACIFIC INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  99. TABLE 86 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
  100. TABLE 87 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  101. TABLE 88 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  102. TABLE 89 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  103. TABLE 90 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  104. TABLE 91 BRAZI INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  105. TABLE 92 BRAZIL INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  106. TABLE 93 BRAZIL INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  107. TABLE 94 BRAZIL INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  108. TABLE 95 MEXICO INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  109. TABLE 96 MEXICO INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  110. TABLE 97 MEXICO INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  111. TABLE 98 MEXICO INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  112. TABLE 99 ARGENTINA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  113. TABLE 100 ARGENTINA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  114. TABLE 101 ARGENTINA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  115. TABLE 102 ARGENTINA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  116. TABLE 103 REST OF SOUTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  117. TABLE 104 REST OF SOUTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  118. TABLE 105 REST OF SOUTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  119. TABLE 106 REST OF SOUTH AMERICA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  120. TABLE 107 MIDDLE EAST & AFRICA: INTRAVENOUS (IV) IRON, BY COUNTRY, 2019-2035 (USD MILLION)
  121. TABLE 108 MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  122. TABLE 109 MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  123. TABLE 110 MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  124. TABLE 111 MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  125. TABLE 112 GCC COUNTRIES INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  126. TABLE 113 GCC COUNTRIES INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  127. TABLE 114 GCC COUNTRIES INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  128. TABLE 115 GCC COUNTRIES INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  129. TABLE 116 SOUTH AFRICA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  130. TABLE 117 SOUTH AFRICA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  131. TABLE 118 SOUTH AFRICA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  132. TABLE 119 SOUTH AFRICA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  133. TABLE 120 REST OF MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION)
  134. TABLE 121 REST OF MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  135. TABLE 122 REST OF MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
  136. TABLE 123 REST OF MIDDLE EAST & AFRICA INTRAVENOUS (IV) IRON MARKET, BY END USER, 2019-2035 (USD MILLION)
  137. TABLE 124 PUBLIC PLAYERS STOCK SUMMARY
  138. TABLE 125 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  139. TABLE 126 COMPETITOR'S PRODUCT INFORMATION/ PRODUCT BENCHMARKING ANALYSIS
  140. TABLE 127 NEW PRODUCT LAUNCH
  141. TABLE 128 PARTNERSHIP/COLLABORATION, INVESTMENT, EXPANSION, AND OTHERS
  142. TABLE 129 ABBVIE INC.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  143. TABLE 130 ABBVIE INC.: KEY DEVELOPMENTS
  144. TABLE 131 AZURITY PHARMACEUTICALS: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  145. TABLE 132 AZURITY PHARMACEUTICALS: KEY DEVELOPMENTS
  146. TABLE 133 DAIICHI SANKYO COMPANY, LTD.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  147. TABLE 134 DAIICHI SANKYO COMPANY, LTD.: KEY DEVELOPMENTS
  148. TABLE 135 SANOFI: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  149. TABLE 136 SANOFI: KEY DEVELOPMENTS
  150. TABLE 137 VIFOR PHARMA (CSL): PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  151. TABLE 138 VIFOR PHARMA (CSL): KEY DEVELOPMENTS
  152. TABLE 139 PHARMACOSMOS A/S.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  153. TABLE 140 PHARMACOSMOS A/S.: KEY DEVELOPMENTS
  154. TABLE 141 ZYDUS GROUP.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  155. TABLE 142 ZYDUS GROUP.: KEY DEVELOPMENTS
  156. TABLE 143 ROCKWELL MEDICAL, INC.: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  157. TABLE 144 ROCKWELL MEDICAL, INC..: KEY DEVELOPMENTS
  158. TABLE 145 SHIELD THERAPEUTICS: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  159. TABLE 146 SHIELD THERAPEUTICS. KG: KEY DEVELOPMENTS
  160. TABLE 147 AMERICAN REGENT, INC: PRODUCTS/ SOLUTIONS/ SERVICES OFFERED
  161. LIST OF FIGURES
  162. FIGURE 1 GLOBAL INTRAVENOUS (IV) IRON MARKET: STRUCTURE
  163. FIGURE 2 GLOBAL INTRAVENOUS (IV) IRON MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
  164. FIGURE 3 DRIVER IMPACT ANALYSIS (2019-2035)
  165. FIGURE 4 RESTRAINT IMPACT ANALYSIS (2019-2035)
  166. FIGURE 5 OPPORTUNITY IMPACT FORECAST
  167. FIGURE 1 PORTER’S FIVE FORCES MODEL: GLOBAL INTRAVENOUS (IV) IRON MARKET
  168. FIGURE 2 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2024 & 2035 (USD MILLION)
  169. FIGURE 3 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY PRODUCT TYPE, 2024 (% SHARE)
  170. FIGURE 4 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
  171. FIGURE 5 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY APPLICATION, 2024 (% SHARE)
  172. FIGURE 6 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2024 & 2035 (USD MILLION)
  173. FIGURE 7 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  174. FIGURE 8 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY END USER, 2024 & 2035 (USD MILLION)
  175. FIGURE 9 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY END USER, 2024 (% SHARE)
  176. FIGURE 10 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY REGION, 2024 (% SHARE)
  177. FIGURE 11 GLOBAL INTRAVENOUS (IV) IRON MARKET, BY REGION, 2023 VS 2032 (USD MILLION)
  178. FIGURE 12 NORTH AMERICA MARKET ANALYSIS: INTRAVENOUS (IV) IRON MARKET, 2019-2035 (USD MILLION)
  179. FIGURE 13 NORTH AMERICA: INTRAVENOUS (IV) IRON MARKET SHARE, BY COUNTRY, 2024 (% SHARE)
  180. FIGURE 14 EUROPE MARKET ANALYSIS: INTRAVENOUS (IV) IRON MARKET, 2019-2035 (USD MILLION)
  181. FIGURE 15 EUROPE: INTRAVENOUS (IV) IRON MARKET SHARE, BY COUNTRY, 2024 (% SHARE)
  182. FIGURE 16 ASIA-PACIFIC MARKET ANALYSIS: INTRAVENOUS (IV) IRON MARKET, 2019-2035 (USD MILLION)
  183. FIGURE 17 ASIA-PACIFIC: INTRAVENOUS (IV) IRON MARKET SHARE, BY COUNTRY, 2024 (% SHARE)
  184. FIGURE 18 SOUTH AMERICA MARKET ANALYSIS: INTRAVENONUS (IV) IRON MARKET, 2019-2035 (USD MILLION)
  185. FIGURE 19 SOUTH AMERICA: INTRAVENONUS (IV) IRON MARKET SHARE, BY COUNTRY, 2024 (% SHARE)
  186. FIGURE 20 MIDDLE EAST AND AFRICA MARKET ANALYSIS: INTRAVENOUS (IV) IRON MARKET, 2019-2035 (USD MILLION)
  187. FIGURE 21 MIDDLE EAST & AFRICA: INTRAVENOUS (IV) IRON MARKET SHARE, BY COUNTRY, 2024 (% SHARE)
  188. FIGURE 22 GLOBAL INTRAVENOUS (IV) IRON PLAYERS: COMPETITIVE ANALYSIS, 2024 (USD BILLION) (% SHARE)
  189. FIGURE 23 COMPETITOR DASHBOARD: GLOBAL INTRAVENOUS (IV) IRON MARKET
  190. FIGURE 39 SHIELD THERAPEUTICS: SWOT ANALYSIS
  191. FIGURE 40 AMERICAN REGENT, INC: SWOT ANALYSIS

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

o Intravenous (IV) Iron Market Regional Outlook (USD Million, 2019-2035)

North America Outlook (USD Million, 2019-2035)

North America Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

North America Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

North America Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

North America Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

US Outlook (USD Million, 2019-2035)

US Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

US Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

US Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

US Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Canada Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Europe Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

GermanyOutlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

UK Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

France Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Russia Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Italy Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Spain Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Rest Of Europe Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others     

Asia-Pacific Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

China Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

India Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Japan Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

South Korea Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Rest of Asia-Pacific Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

South America Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Brazil Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Mexico Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Argentina Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Rest of South America Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Middle East & Africa Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

GCC Countries Outlook (USD Million, 2019-2035)

Global Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Global Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Global Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Global Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

South Africa Outlook (USD Million, 2019-2035)

South Africa Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

South Africa Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

South Africa Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

South Africa Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Rest of Middle East & Africa Outlook (USD Million, 2019-2035)

Rest of Middle East & Africa Intravenous (IV) Iron Market by Product Type Outlook (USD Million, 2019-2035)

Ferric Carboxymaltose

Ferumoxytol

Iron Sucrose

Iron Isomaltoside

Ferric Gluconate

Iron Dextran

Others

Rest of Middle East & Africa Intravenous (IV) Iron Market by Application Outlook (USD Million, 2019-2035)

Anemia in Chronic Kidney Disease (CKD)

Anemia in Oncology

Iron Deficiency in Heart Failure

Iron Deficiency Anemia (IDA) in Non-Dialysis Patients

Others

Rest of Middle East & Africa Intravenous (IV) Iron Market by Distribution Channel Outlook (USD Million, 2019-2035)

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Rest of Middle East & Africa Intravenous (IV) Iron Market by End User Outlook (USD Million, 2019-2035)

Hospitals and Clinics

Specialized Infusion Centers

Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓